Filspari Prices, Coupons, Copay Cards & Patient Assistance
Filspari (sparsentan) is a member of the miscellaneous cardiovascular agents drug class and is commonly used for Immunoglobulin A Nephropathy.
Filspari is available as a brand name drug only, a generic version is not yet available. View generic Filspari availability for more details.
Filspari prices
Oral Tablet
200 mg Filspari oral tablet from $13,281.69 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $442.72 | $13,281.69 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
400 mg Filspari oral tablet from $13,281.69 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $442.72 | $13,281.69 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Filspari Coupons, Copay Cards and Rebates
Filspari offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Filspari Copay Program
Eligible commercially insured patients may pay as little as $0 per month.
- Applies to:
- Filspari
- Number of uses:
- Per prescription until program expires
Form more information phone: 833-345-7727 or Visit website
Patient Assistance & Copay Programs for Filspari
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Travere TotalCare: Filspari
Eligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- The patient must be a US citizen or legal resident.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Prescribing Physician, Healthcare Facilities, Pharmacies and Patients must enroll into the Risk Evaluation and Mitigation Strategy (REMS) Program prior to initiating the patient on treatment with Filspari. Contact program for more detail.
- Filspari (sparsentan) Tablet
More information please phone: 833-345-7727 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Tarpeyo
Tarpeyo (budesonide) is an oral, delayed-release, corticosteroid capsule that may be used to reduce ...
Pulmicort Turbuhaler
Pulmicort (budesonide) is used to prevent asthma attacks. Includes Pulmicort side effects ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Vanrafia
Vanrafia (atrasentan) is a once-a-day non-steroidal tablet used for immunoglobulin A nephropathy ...
Eohilia
Eohilia (budesonide) suspension is used to treat eosinophilic esophagitis (EoE), to reduce symptoms ...
Entocort EC
Entocort EC is used to treat active, mild to moderate Crohn's disease (CD) that involves the ileum ...
Fabhalta
Fabhalta is used to treat paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
More about Filspari (sparsentan)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous cardiovascular agents
- En español